Medical and Pharmaceutical Industry - Market Research Report

The global foot and ankle devices market size is expected to reach USD 7.13 billion by 2030, registering a CAGR of 7.10% from 2025 to 2030, according to a new report by Grand View Research, Inc. This is due to the rapidly developing healthcare infrastructure, the increasing number of foot & ankle surgical procedures, the increased incidence of obesity & diabetes, and the growing use of patient-specific solutions. Moreover, innovation and product development due to expenditure on R&D by major companies are some of the factors propelling the growth of the industry. After the SARS-CoV-2 (COVID-19) crisis in Wuhan in December 2019, it spread quickly around the world and affected both developed and developing countries’ healthcare systems, in terms of health and non-health issues. The spread of the COVID-19 infection was slowed down by mobility restrictions and stay-at-home directives. However, this created an obstacle in foot and ankle devices intended for the effective treatm...

 The global medical image analysis software market size is expected to reach USD 5.48 billion by 2030, expanding at a CAGR of 7.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of chronic diseases creates demand for effective diagnostics solutions, which spurs the demand for medical image analysis software. The high growth is majorly attributed to a rise in the usage and uptake of image analysis solutions for diagnosis. Furthermore, the rising demand for medical image analysis software is being driven by the increased use of imaging equipment due to the rising prevalence of chronic diseases and developing applications of computer-aided diagnosis. According to data by the National Health Council, in 2020, around 133 million Americans were affected by chronic diseases, accounting for more than 40% of the country’s total population. Thus, increasing cases of chronic diseases lead to an upsurge in the usage of medical imaging techniques...

  The global coronary stents market size is expected to reach USD 9.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.6% from 2025 to 2030.  Increasing adoption of minimally invasive surgeries and Percutaneous Coronary Intervention (PCI) procedures is expected to drive the market in the coming years. For instance, according to The Korean Journal of Thoracic and Cardiovascular Surgery, the proportion of PCI for Coronary Artery Disease (CAD) was 78% in 2016, and the country-specific PCI proportion was 96%, which was significantly higher than the global average. As a result, the unprecedented growth in CAD incidence, along with an increase in the proportion of PCIs done in these CAD patients, is expected to raise demand for an effective coronary stent technology. Technological advancement and the launch of 2nd generation drug-eluting stents are further fueling the growth. For instance, Abbott Laboratories Lab...

  The global ophthalmic drugs market size is expected to reach USD 66.06 billion by 2030, garnering a CAGR of 7.80% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising awareness about ophthalmic disorders and the surge in demand for ophthalmic drugs are the factors propelling the market growth. Moreover, an increase in the prevalence of eye diseases such as age-related macular degeneration, cataract, dry eye, diabetic retinopathy, glaucoma, and others are anticipated to boost the demand for ophthalmic drugs. According to BrightFocus Foundation in 2021, it is estimated that over 3 million Americans are living with glaucoma, and, among them over 2.7 million patients were affected by the most common type of glaucoma i.e. open-angle glaucoma. Moreover, 3.3 million people are affected by blindness and low vision in the U.S. Some of the major risk factors for glaucoma and blindness are, higher age, family history, thin cornea, and high eye pressure. This ...

  The global molecular diagnostics market size is estimated to reach USD 33.08 billion by 2030, expanding at a CAGR of 3.97% from 2025 to 2030, according to a new report by Grand View Research, Inc. The contraction in the market will be due to the decline in demand for molecular testing for COVID-19. However, factors such as the rising geriatric population and increasing demand for technologies such as NGS is expected to drive market growth. Molecular diagnostics plays an important role in infectious disease testing as they can yield effective and fast results. Hence, the increasing prevalence of hospital-acquired infections & infectious diseases is projected to drive the market over the forecast period. Increasing incidence and awareness regarding genetic disorders is further anticipated to accelerate market growth. The miniaturization of three basic molecular assays-nanobiotechnology, biochips, and microfluidics are expected to increase the accuracy and specificity of diagnos...

The global cell therapy market size is expected to reach USD 20.07 billion by 2030, expanding at a CAGR of 22.66% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market players are witnessing an increasing interest in the development of advanced therapies that are based on tissue, genes, or cells. Research communities and companies continue to make large investments in the culturing and isolation of a broad range of cell types, such as keratinocytes, chondrocytes, cartilage, stem, dermal papilla, & epithelial cells for the development of novel therapies. Regulatory authorities such as FDA play a crucial role in the growth of the market by undertaking initiatives related to the development and approval of advanced treatment development as well as restriction of unregulated treatments. In addition, direct cellular reprogramming is attracting interest as a cutting-edge treatment approach because of its advantages such as efficacy and security. On the ot...

  The global influenza vaccine market size is expected to reach USD 12.58 billion by 2030 and is set to expand at 6.98% CAGR from 2024 to 2030, according to a new report by Grand View Research, Inc. The increase in immunization programs, rising awareness regarding flu and influenza, and surge in R&D activities pertaining to flu vaccines are anticipated to propel market growth. In addition, the inclusion of the influenza vaccine in various national immunization programs and increasing awareness programs for immunizations across the globe is anticipated to boost the market growth. The ongoing influenza vaccination national schemes globally are anticipated to propel the market. For instance, programs such as Universal Influenza Immunization Program and NIP Vaccination Programs among others are some of the key immunization programs. These offer flu vaccines free of cost to all the target population. The key objective of such programs is to eliminate the risk of flu-like disorders. ...

  The global hunter syndrome treatment market size is expected to reach a value of USD 1.78 billion by 2030, expanding at a CAGR of 5.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. High unmet needs, robust pipeline, increasing awareness about this rare disease and growing R&D activities for the development of novel therapies are expected to drive market growth over the forecast period. Hunter syndrome, also referred as mucopolysaccharidosis type II (MPS II), is a rare genetic disorder caused by the missing or malfunctioning iduronate-2-sulfatase enzyme. According to the data published by the National Institute of Neurological Disorders and Stroke, MPS II syndrome occurs in around 1 in every 100,000 to 150,000 male births. Presently, there are no approved curative therapies for the treatment of Hunter syndrome. The available treatment options such as enzyme replacement therapy (ERT) and hematopoietic stem cell transplant (HSCT) are focused on provid...

  The global gasoline direct injection market size was estimated at USD 9.13 billion in 2023 and is projected to reach at a CAGR of 8.1% from 2024 to 2030. The increasing demand for fuel-efficient and high-performance engines in passenger and commercial vehicles is driving the adoption of gasoline direct injection across the automotive industry. gasoline direct injection (GDI) systems offer improved fuel economy, lower emissions, and enhanced engine performance, making them a preferred choice among automakers aiming to meet stringent environmental regulations. The gasoline direct injection market is also witnessing significant growth due to advancements in engine technologies and the rising trend of downsized engines without compromising power output. As consumers and manufacturers alike seek to balance performance with fuel efficiency, GDI systems have emerged as a critical technology in modern vehicle design. The expanding electric vehicle (EV) market presents both a challenge an...

  The global eggshell membrane market size is projected to reach USD 247 million by 2028, according to a new report by Grand View Research, Inc., expanding at a CAGR of 9.3% from 2020 to 2028. The change in consumer lifestyle and transition in consumption patterns have encouraged the use of eggshell membrane as an ingredient in the nutraceuticals and food and beverage industries. The market is expected to witness growth opportunities in preventive skincare and healthcare applications owing to the number of advantages offered by the eggshell membranes. Reduced risk of osteoporosis, improvement in joint health, and an increase in the consumption of eggshell membranes in nutraceutical applications as an active ingredient are some of the factors projected to boost the market growth during the forecast period. The industry is majorly driven by the growth in the adoption of the eggshell membrane as an ingredient in nutraceutical products. Growing application in cosmetic and personal care...